Chaoju Eye Care Holdings (02219) disclosed that the total number of issued shares remained at 707,510,500 as of December 4, 2025. The company carried out eight share repurchases totaling 120,000 shares each on November 19, November 20, November 21, November 24, November 26, November 28, December 2, and December 4, all of which had yet to be canceled as of the reporting date.

According to the repurchase report, an additional 120,000 shares were repurchased on December 4 at prices ranging between HKD 2.63 and HKD 2.70, for an aggregate price of HKD 319,225. These repurchases were authorized under a mandate dated June 6, 2025, which allows up to 70,751,050 shares to be repurchased. As of the disclosure, a total of 960,000 shares have been repurchased under this mandate, representing approximately 0.136% of the issued shares at the time of the mandate's approval. A moratorium on issuing new shares or dealing in treasury shares remains in place until January 4, 2026.